aluates Reports

$ 7800.0

Automative

Antipsychotics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-6E7358

Global Antipsychotics Market Insights and Forecast to 2028

BUY CHAPTERS

Antipsychotics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6E7358

Report

September 2024

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

Pfizer Inc

Eli Lilly & Co

Bristol–Myers Squibb

Astrazeneca plc

Glaxo Smithkline

Allergan plc

Antipsychotics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antipsychotics - Market

Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.

The global market for Antipsychotics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antipsychotics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antipsychotics by region & country, by Type, and by Application.

The Antipsychotics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotics.

Market Segmentation

Scope of Antipsychotics - Market Report

Report Metric	Details
Report Name	Antipsychotics - Market
CAGR	5%
Segment by Type:	First Generation Second Generation Third Generation
Segment by Application	Schizophrenia Bipolar Disorder Unipolar Depression Dementia Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Pfizer, Eli Lilly & Co, Bristol-Myers Squibb, AstraZeneca, Glaxo SmithKline, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antipsychotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antipsychotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antipsychotics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Antipsychotics - Market report?

Ans: The main players in the Antipsychotics - Market are Johnson & Johnson, Pfizer, Eli Lilly & Co, Bristol-Myers Squibb, AstraZeneca, Glaxo SmithKline, Allergan

What are the Application segmentation covered in the Antipsychotics - Market report?

Ans: The Applications covered in the Antipsychotics - Market report are Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Others

What are the Type segmentation covered in the Antipsychotics - Market report?

Ans: The Types covered in the Antipsychotics - Market report are First Generation, Second Generation, Third Generation

Recommended Reports

Neuropsychiatric Disorders

Neurodegenerative Disease

Psychiatric and Therapy Drugs

1 Market Overview

1.1 Antipsychotics Product Introduction

1.2 Global Antipsychotics Market Size Forecast

1.2.1 Global Antipsychotics Sales Value (2019-2030)

1.2.2 Global Antipsychotics Sales Volume (2019-2030)

1.2.3 Global Antipsychotics Sales Price (2019-2030)

1.3 Antipsychotics Market Trends & Drivers

1.3.1 Antipsychotics Industry Trends

1.3.2 Antipsychotics Market Drivers & Opportunity

1.3.3 Antipsychotics Market Challenges

1.3.4 Antipsychotics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Antipsychotics Players Revenue Ranking (2023)

2.2 Global Antipsychotics Revenue by Company (2019-2024)

2.3 Global Antipsychotics Players Sales Volume Ranking (2023)

2.4 Global Antipsychotics Sales Volume by Company Players (2019-2024)

2.5 Global Antipsychotics Average Price by Company (2019-2024)

2.6 Key Manufacturers Antipsychotics Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Antipsychotics Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Antipsychotics

2.9 Antipsychotics Market Competitive Analysis

2.9.1 Antipsychotics Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Antipsychotics Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotics as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 First Generation

3.1.2 Second Generation

3.1.3 Third Generation

3.2 Global Antipsychotics Sales Value by Type

3.2.1 Global Antipsychotics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Antipsychotics Sales Value, by Type (2019-2030)

3.2.3 Global Antipsychotics Sales Value, by Type (%) (2019-2030)

3.3 Global Antipsychotics Sales Volume by Type

3.3.1 Global Antipsychotics Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Antipsychotics Sales Volume, by Type (2019-2030)

3.3.3 Global Antipsychotics Sales Volume, by Type (%) (2019-2030)

3.4 Global Antipsychotics Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Schizophrenia

4.1.2 Bipolar Disorder

4.1.3 Unipolar Depression

4.1.4 Dementia

4.1.5 Others

4.2 Global Antipsychotics Sales Value by Application

4.2.1 Global Antipsychotics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Antipsychotics Sales Value, by Application (2019-2030)

4.2.3 Global Antipsychotics Sales Value, by Application (%) (2019-2030)

4.3 Global Antipsychotics Sales Volume by Application

4.3.1 Global Antipsychotics Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Antipsychotics Sales Volume, by Application (2019-2030)

4.3.3 Global Antipsychotics Sales Volume, by Application (%) (2019-2030)

4.4 Global Antipsychotics Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Antipsychotics Sales Value by Region

5.1.1 Global Antipsychotics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Antipsychotics Sales Value by Region (2019-2024)

5.1.3 Global Antipsychotics Sales Value by Region (2025-2030)

5.1.4 Global Antipsychotics Sales Value by Region (%), (2019-2030)

5.2 Global Antipsychotics Sales Volume by Region

5.2.1 Global Antipsychotics Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Antipsychotics Sales Volume by Region (2019-2024)

5.2.3 Global Antipsychotics Sales Volume by Region (2025-2030)

5.2.4 Global Antipsychotics Sales Volume by Region (%), (2019-2030)

5.3 Global Antipsychotics Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Antipsychotics Sales Value, 2019-2030

5.4.2 North America Antipsychotics Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Antipsychotics Sales Value, 2019-2030

5.5.2 Europe Antipsychotics Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Antipsychotics Sales Value, 2019-2030

5.6.2 Asia Pacific Antipsychotics Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Antipsychotics Sales Value, 2019-2030

5.7.2 South America Antipsychotics Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Antipsychotics Sales Value, 2019-2030

5.8.2 Middle East & Africa Antipsychotics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Antipsychotics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Antipsychotics Sales Value

6.2.1 Key Countries/Regions Antipsychotics Sales Value, 2019-2030

6.2.2 Key Countries/Regions Antipsychotics Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Antipsychotics Sales Value, 2019-2030

6.3.2 United States Antipsychotics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Antipsychotics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Antipsychotics Sales Value, 2019-2030

6.4.2 Europe Antipsychotics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Antipsychotics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Antipsychotics Sales Value, 2019-2030

6.5.2 China Antipsychotics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Antipsychotics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Antipsychotics Sales Value, 2019-2030

6.6.2 Japan Antipsychotics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Antipsychotics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Antipsychotics Sales Value, 2019-2030

6.7.2 South Korea Antipsychotics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Antipsychotics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Antipsychotics Sales Value, 2019-2030

6.8.2 Southeast Asia Antipsychotics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Antipsychotics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Antipsychotics Sales Value, 2019-2030

6.9.2 India Antipsychotics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Antipsychotics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Company Information

7.1.2 Johnson & Johnson Introduction and Business Overview

7.1.3 Johnson & Johnson Antipsychotics Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Johnson & Johnson Antipsychotics Product Offerings

7.1.5 Johnson & Johnson Recent Development

7.2 Pfizer

7.2.1 Pfizer Company Information

7.2.2 Pfizer Introduction and Business Overview

7.2.3 Pfizer Antipsychotics Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer Antipsychotics Product Offerings

7.2.5 Pfizer Recent Development

7.3 Eli Lilly & Co

7.3.1 Eli Lilly & Co Company Information

7.3.2 Eli Lilly & Co Introduction and Business Overview

7.3.3 Eli Lilly & Co Antipsychotics Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Eli Lilly & Co Antipsychotics Product Offerings

7.3.5 Eli Lilly & Co Recent Development

7.4 Bristol-Myers Squibb

7.4.1 Bristol-Myers Squibb Company Information

7.4.2 Bristol-Myers Squibb Introduction and Business Overview

7.4.3 Bristol-Myers Squibb Antipsychotics Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Bristol-Myers Squibb Antipsychotics Product Offerings

7.4.5 Bristol-Myers Squibb Recent Development

7.5 AstraZeneca

7.5.1 AstraZeneca Company Information

7.5.2 AstraZeneca Introduction and Business Overview

7.5.3 AstraZeneca Antipsychotics Sales, Revenue and Gross Margin (2019-2024)

7.5.4 AstraZeneca Antipsychotics Product Offerings

7.5.5 AstraZeneca Recent Development

7.6 Glaxo SmithKline

7.6.1 Glaxo SmithKline Company Information

7.6.2 Glaxo SmithKline Introduction and Business Overview

7.6.3 Glaxo SmithKline Antipsychotics Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Glaxo SmithKline Antipsychotics Product Offerings

7.6.5 Glaxo SmithKline Recent Development

7.7 Allergan

7.7.1 Allergan Company Information

7.7.2 Allergan Introduction and Business Overview

7.7.3 Allergan Antipsychotics Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Allergan Antipsychotics Product Offerings

7.7.5 Allergan Recent Development

8 Industry Chain Analysis

8.1 Antipsychotics Industrial Chain

8.2 Antipsychotics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Antipsychotics Sales Model

8.5.2 Sales Channel

8.5.3 Antipsychotics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Pfizer Inc

Eli Lilly & Co

Bristol–Myers Squibb

Astrazeneca plc

Glaxo Smithkline

Allergan plc

List of Tables

Table 1. Antipsychotics Market Trends

Table 2. Antipsychotics Market Drivers & Opportunity

Table 3. Antipsychotics Market Challenges

Table 4. Antipsychotics Market Restraints

Table 5. Global Antipsychotics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Antipsychotics Revenue Market Share by Company (2019-2024)

Table 7. Global Antipsychotics Sales Volume by Company (2019-2024) & (K MT)

Table 8. Global Antipsychotics Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Antipsychotics Price by Company (2019-2024) & (USD/MT)

Table 10. Key Manufacturers Antipsychotics Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Antipsychotics Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Antipsychotics

Table 13. Global Antipsychotics Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotics as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Antipsychotics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Antipsychotics Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Antipsychotics Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Antipsychotics Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Antipsychotics Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Antipsychotics Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)

Table 22. Global Antipsychotics Sales Volume by Type (2019-2024) & (K MT)

Table 23. Global Antipsychotics Sales Volume by Type (2025-2030) & (K MT)

Table 24. Global Antipsychotics Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Antipsychotics Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Antipsychotics Price by Type (2019-2024) & (USD/MT)

Table 27. Global Antipsychotics Price by Type (2025-2030) & (USD/MT)

Table 28. Global Antipsychotics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Antipsychotics Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Antipsychotics Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Antipsychotics Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Antipsychotics Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Antipsychotics Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)

Table 34. Global Antipsychotics Sales Volume by Application (2019-2024) & (K MT)

Table 35. Global Antipsychotics Sales Volume by Application (2025-2030) & (K MT)

Table 36. Global Antipsychotics Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Antipsychotics Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Antipsychotics Price by Application (2019-2024) & (USD/MT)

Table 39. Global Antipsychotics Price by Application (2025-2030) & (USD/MT)

Table 40. Global Antipsychotics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Antipsychotics Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Antipsychotics Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Antipsychotics Sales Value by Region (2019-2024) & (%)

Table 44. Global Antipsychotics Sales Value by Region (2025-2030) & (%)

Table 45. Global Antipsychotics Sales Volume by Region (K MT): 2019 VS 2023 VS 2030

Table 46. Global Antipsychotics Sales Volume by Region (2019-2024) & (K MT)

Table 47. Global Antipsychotics Sales Volume by Region (2025-2030) & (K MT)

Table 48. Global Antipsychotics Sales Volume by Region (2019-2024) & (%)

Table 49. Global Antipsychotics Sales Volume by Region (2025-2030) & (%)

Table 50. Global Antipsychotics Average Price by Region (2019-2024) & (USD/MT)

Table 51. Global Antipsychotics Average Price by Region (2025-2030) & (USD/MT)

Table 52. Key Countries/Regions Antipsychotics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Antipsychotics Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Antipsychotics Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Antipsychotics Sales Volume, (2019-2024) & (K MT)

Table 56. Key Countries/Regions Antipsychotics Sales Volume, (2025-2030) & (K MT)

Table 57. Johnson & Johnson Company Information

Table 58. Johnson & Johnson Introduction and Business Overview

Table 59. Johnson & Johnson Antipsychotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 60. Johnson & Johnson Antipsychotics Product Offerings

Table 61. Johnson & Johnson Recent Development

Table 62. Pfizer Company Information

Table 63. Pfizer Introduction and Business Overview

Table 64. Pfizer Antipsychotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 65. Pfizer Antipsychotics Product Offerings

Table 66. Pfizer Recent Development

Table 67. Eli Lilly & Co Company Information

Table 68. Eli Lilly & Co Introduction and Business Overview

Table 69. Eli Lilly & Co Antipsychotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 70. Eli Lilly & Co Antipsychotics Product Offerings

Table 71. Eli Lilly & Co Recent Development

Table 72. Bristol-Myers Squibb Company Information

Table 73. Bristol-Myers Squibb Introduction and Business Overview

Table 74. Bristol-Myers Squibb Antipsychotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 75. Bristol-Myers Squibb Antipsychotics Product Offerings

Table 76. Bristol-Myers Squibb Recent Development

Table 77. AstraZeneca Company Information

Table 78. AstraZeneca Introduction and Business Overview

Table 79. AstraZeneca Antipsychotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 80. AstraZeneca Antipsychotics Product Offerings

Table 81. AstraZeneca Recent Development

Table 82. Glaxo SmithKline Company Information

Table 83. Glaxo SmithKline Introduction and Business Overview

Table 84. Glaxo SmithKline Antipsychotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 85. Glaxo SmithKline Antipsychotics Product Offerings

Table 86. Glaxo SmithKline Recent Development

Table 87. Allergan Company Information

Table 88. Allergan Introduction and Business Overview

Table 89. Allergan Antipsychotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 90. Allergan Antipsychotics Product Offerings

Table 91. Allergan Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Antipsychotics Downstream Customers

Table 95. Antipsychotics Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Antipsychotics Product Picture

Figure 2. Global Antipsychotics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Antipsychotics Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Antipsychotics Sales Volume (2019-2030) & (K MT)

Figure 5. Global Antipsychotics Sales Price (2019-2030) & (USD/MT)

Figure 6. Antipsychotics Report Years Considered

Figure 7. Global Antipsychotics Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Antipsychotics Players Sales Volume Ranking (2023) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antipsychotics Revenue in 2023

Figure 10. Antipsychotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. First Generation Picture

Figure 12. Second Generation Picture

Figure 13. Third Generation Picture

Figure 14. Global Antipsychotics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Antipsychotics Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Antipsychotics Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)

Figure 17. Global Antipsychotics Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Antipsychotics Price by Type (2019-2030) & (USD/MT)

Figure 19. Product Picture of Schizophrenia

Figure 20. Product Picture of Bipolar Disorder

Figure 21. Product Picture of Unipolar Depression

Figure 22. Product Picture of Dementia

Figure 23. Product Picture of Others

Figure 24. Global Antipsychotics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Antipsychotics Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Antipsychotics Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)

Figure 27. Global Antipsychotics Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Antipsychotics Price by Application (2019-2030) & (USD/MT)

Figure 29. North America Antipsychotics Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Antipsychotics Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Antipsychotics Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Antipsychotics Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Antipsychotics Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Antipsychotics Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Antipsychotics Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Antipsychotics Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Antipsychotics Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Antipsychotics Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Antipsychotics Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Antipsychotics Sales Volume (%), (2019-2030)

Figure 41. United States Antipsychotics Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Antipsychotics Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Antipsychotics Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Antipsychotics Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Antipsychotics Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Antipsychotics Sales Value by Application (%), 2023 VS 2030

Figure 47. China Antipsychotics Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Antipsychotics Sales Value by Type (%), 2023 VS 2030

Figure 49. China Antipsychotics Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Antipsychotics Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Antipsychotics Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Antipsychotics Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Antipsychotics Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Antipsychotics Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Antipsychotics Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Antipsychotics Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Antipsychotics Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Antipsychotics Sales Value by Application (%), 2023 VS 2030

Figure 59. India Antipsychotics Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Antipsychotics Sales Value by Type (%), 2023 VS 2030

Figure 61. India Antipsychotics Sales Value by Application (%), 2023 VS 2030

Figure 62. Antipsychotics Industrial Chain

Figure 63. Antipsychotics Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antipsychotic Medications Market Research Report 2024

Global Long acting Antipsychotic Market Research Report 2024

Global Antipsychotic Drug Market Research Report 2024

Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Atypical Antipsychotic Drugs Market Insights Forecast to 2030

Psychotropic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long Acting Schizophrenia Drug Market Research Report 2024

Global Anti schizophrenic Drugs Market Research Report 2025

Iloperidone Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neuroleptic Market Research Report 2025

Long Acting Injectable LAI Antipsychotic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psychiatric Medication Therapies Market Research Report 2024

Lithium Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Risperidone API Market Research Report 2025

Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Loxapine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Long acting Injectable Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Major Tranquilizers Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Antipsychotics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-6E7358

Antipsychotics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Antipsychotics - Market Size

Antipsychotics - Market

Report Scope

Scope of Antipsychotics - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Antipsychotics - Market report?

What are the Application segmentation covered in the Antipsychotics - Market report?

What are the Type segmentation covered in the Antipsychotics - Market report?

Recommended Reports

Neuropsychiatric Disorders

Neurodegenerative Disease

Psychiatric and Therapy Drugs

FEATURED COMPANIES

Genomics Market

Single User, Electronic (PDF)

Global mHealth Apps Market Size Status and Forecast 2021 to 2027

Single User, Electronic (PDF)